Advertisement Pharmaceutical Business review - Page 4113 of 5287 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 24, 2026

Gossamer Bio announces $250m in funding to advance seralutinib

Gossamer Bio has announced a private placement agreement valued at up to $250m, including $150m of committed capital intended to support the development and potential US Food and Drug Administration (FDA) approval of seralutinib.

Continue
Seralutinib is intended for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. Credit: Green Apple/Shutterstock.com.
August 24, 2026

Johnson & Johnson’s multiple myeloma treatment secures EC approval

The decision provides a new therapeutic option for patients with r/r MM. Credit: luchschenF / Shutterstock.com.
August 20, 2026

SandboxAQ introduces AQPotency for virtual drug screening

AQPotency addresses shortcomings by providing rapid ranking of molecule-target pairs. Credit: Gorodenkoff / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. WellSpan and Johns Hopkins renew partnership for advanced cancer care access
  2. Charles River and MVC to develop enterovirus vaccine
  3. FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
  4. Andelyn Biosciences to develop GM2 gangliosidosis therapy
  5. BeOne Medicines and partners renew Brukinsa access programme for CLL

PRESS RELEASES

SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography